<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-QWTKZyjpPEjISv5WaRU9OFeRpok6YctnYmDr5pNlyT2bRjXh0JMhjY6hW+ALEwIH" crossorigin="anonymous">
    <link rel="stylesheet" href="style.css">
    <title>Publications</title>
</head>
<body>


<!-- Navigation bar -->
    <div class="container d-flex justify-content-center my-4">
        <nav class="navbar navbar-expand-lg ">
            <div class="container-fluid  ">
              <button class="navbar-toggler mx-auto" type="button" data-bs-toggle="collapse" data-bs-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation">
                <span class="navbar-toggler-icon"></span>
              </button>
              <div class="collapse navbar-collapse text-center" id="navbarNavAltMarkup">
                <div class="navbar-nav h1 fw-regular">
                  <a class="nav-link px-3" href="index.html">Home</a>
                  <a class="nav-link active px-3" aria-current="page" href="publications.html">Publications</a>
                  <a class="nav-link px-3" href="resources.html">Resources</a>
                  <a class="nav-link px-3" href="https://www.linkedin.com/in/akashmitraa/" target="_blank">
                    <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-linkedin" viewBox="0 0 16 16">
                        <path d="M0 1.146C0 .513.526 0 1.175 0h13.65C15.474 0 16 .513 16 1.146v13.708c0 .633-.526 1.146-1.175 1.146H1.175C.526 16 0 15.487 0 14.854zm4.943 12.248V6.169H2.542v7.225zm-1.2-8.212c.837 0 1.358-.554 1.358-1.248-.015-.709-.52-1.248-1.342-1.248S2.4 3.226 2.4 3.934c0 .694.521 1.248 1.327 1.248zm4.908 8.212V9.359c0-.216.016-.432.08-.586.173-.431.568-.878 1.232-.878.869 0 1.216.662 1.216 1.634v3.865h2.401V9.25c0-2.22-1.184-3.252-2.764-3.252-1.274 0-1.845.7-2.165 1.193v.025h-.016l.016-.025V6.169h-2.4c.03.678 0 7.225 0 7.225z"/>
                      </svg>
                  </a>
                  <a class="nav-link px-3" href="https://github.com/akashmitraa" target= "blank">
                    <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-github" viewBox="0 0 16 16">
                    <path d="M8 0C3.58 0 0 3.58 0 8c0 3.54 2.29 6.53 5.47 7.59.4.07.55-.17.55-.38 0-.19-.01-.82-.01-1.49-2.01.37-2.53-.49-2.69-.94-.09-.23-.48-.94-.82-1.13-.28-.15-.68-.52-.01-.53.63-.01 1.08.58 1.23.82.72 1.21 1.87.87 2.33.66.07-.52.28-.87.51-1.07-1.78-.2-3.64-.89-3.64-3.95 0-.87.31-1.59.82-2.15-.08-.2-.36-1.02.08-2.12 0 0 .67-.21 2.2.82.64-.18 1.32-.27 2-.27s1.36.09 2 .27c1.53-1.04 2.2-.82 2.2-.82.44 1.1.16 1.92.08 2.12.51.56.82 1.27.82 2.15 0 3.07-1.87 3.75-3.65 3.95.29.25.54.73.54 1.48 0 1.07-.01 1.93-.01 2.2 0 .21.15.46.55.38A8.01 8.01 0 0 0 16 8c0-4.42-3.58-8-8-8"/>
                  </svg>
                </a>
                <a class="nav-link px-3" href="https://x.com/akashmitraa" target= "_blank">
                    <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-twitter-x" viewBox="0 0 16 16">
                        <path d="M12.6.75h2.454l-5.36 6.142L16 15.25h-4.937l-3.867-5.07-4.425 5.07H.316l5.733-6.57L0 .75h5.063l3.495 4.633L12.601.75Zm-.86 13.028h1.36L4.323 2.145H2.865z"/>
                      </svg>
                </a>
                <a class="nav-link px-3" href="https://www.youtube.com/@akashmitrabiology" target= "_blank">
                    <svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-youtube" viewBox="0 0 16 16">
                    <path d="M8.051 1.999h.089c.822.003 4.987.033 6.11.335a2.01 2.01 0 0 1 1.415 1.42c.101.38.172.883.22 1.402l.01.104.022.26.008.104c.065.914.073 1.77.074 1.957v.075c-.001.194-.01 1.108-.082 2.06l-.008.105-.009.104c-.05.572-.124 1.14-.235 1.558a2.01 2.01 0 0 1-1.415 1.42c-1.16.312-5.569.334-6.18.335h-.142c-.309 0-1.587-.006-2.927-.052l-.17-.006-.087-.004-.171-.007-.171-.007c-1.11-.049-2.167-.128-2.654-.26a2.01 2.01 0 0 1-1.415-1.419c-.111-.417-.185-.986-.235-1.558L.09 9.82l-.008-.104A31 31 0 0 1 0 7.68v-.123c.002-.215.01-.958.064-1.778l.007-.103.003-.052.008-.104.022-.26.01-.104c.048-.519.119-1.023.22-1.402a2.01 2.01 0 0 1 1.415-1.42c.487-.13 1.544-.21 2.654-.26l.17-.007.172-.006.086-.003.171-.007A100 100 0 0 1 7.858 2zM6.4 5.209v4.818l4.157-2.408z"/>
                    </svg>
                </a>
                </div>
              </div>
            </div>
        </nav>
    </div>

<div class="div d-flex justify-content-center my-5">
  <a href="https://scholar.google.com/citations?user=ri45U0sAAAAJ&hl=en" class="text-center text-secondary h4 fw-light">
    üëâüèª Click here for the full list of articles
  </a>
</div>

<!-- Publication list -->

<div class="container d-flex justify-content-center mb-3">
  <div class="card mb-3" style="max-width: 1080px;">
    <div class="row g-0">
      <div class="col-md-5">
        <img src="images/paper-5.png" class="img-fluid rounded-start" alt="diabetes-induced myopathy">
      </div>
      <div class="col-md-7">
        <div class="card-body">
          <h4 class="card-title">
            Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-¬≠Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in
            C57Bl/6 Mice
          </h4>
          <p class="card-text">Published in The FASEB Journal (2025), this study investigates the protective role of arachidonic acid (AA) in mitigating hyperglycaemia-induced skeletal muscle atrophy using a streptozotocin-induced Type 1 diabetes mouse model. The findings demonstrate that short-term AA supplementation restores muscle mass and integrity by activating muscle stem cells (satellite cells) and reinstating the expression of myogenic regulators such as Pax7, MyoD, and Integrin-Œ±7. Mechanistically, AA downregulates the atrophy-associated transcription factor KLF15, restores the NFŒ∫Œ≤/AMPK signaling balance, and suppresses inflammation and proteolysis. Quantitative proteomic analysis further reveals that AA reverses diabetes-induced dysregulation of proteasomal, metabolic, and structural proteins, highlighting its ability to re-establish cellular homeostasis and promote myogenesis. Together, these results position arachidonic acid as a potent bioactive lipid capable of preserving skeletal muscle integrity and regenerative capacity under diabetic stress, offering new therapeutic insights into metabolic muscle disorders.</p>
          <p class="card-text"><small class="text-body-secondary">The FASEB Journal</small></p>
          <a class="btn btn-light" href="https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202502321RR" role="button">Read more</a>
        </div>
      </div>
    </div>
  </div>
</div>


<div class="container d-flex justify-content-center mb-3">
  <div class="card mb-3" style="max-width: 1080px;">
    <div class="row g-0">
      <div class="col-md-5">
        <img src="images/paper-1.png" class="img-fluid rounded-start" alt="diabetes-induced myopathy">
      </div>
      <div class="col-md-7">
        <div class="card-body">
          <h4 class="card-title">
            Mitigation of chronic glucotoxicity-mediated skeletal muscle atrophy by arachidonic acid
          </h4>
          <p class="card-text">The research paper explores the molecular mechanisms of arachidonic acid (AA) supplementation in reversing the effects of chronic hyperglycemia-induced toxicity on skeletal muscle myogenesis in C2C12 cells. Chronic hyperglycemia activates atrophy-related pathways in skeletal muscles, leading to inflammation and muscle degeneration. The study investigates how AA supplementation mitigates inflammation, reduces reactive oxygen species (ROS) production, and enhances protein synthesis in hyperglycemic conditions. Results show that AA supplementation counteracts the pro-inflammatory cytokines and ROS production induced by high glucose levels, restoring protein synthesis that was suppressed under glucotoxic conditions. The cytoprotective actions of AA against hyperglycemia-induced cytotoxicity are highlighted.</p>
          <p class="card-text"><small class="text-body-secondary">Life Sciences</small></p>
          <a class="btn btn-light" href="https://www.sciencedirect.com/science/article/abs/pii/S0024320523007762?via%3Dihub" role="button">Read more</a>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container d-flex justify-content-center mb-3">
  <div class="card mb-3" style="max-width: 1080px;">
    <div class="row g-0">
      <div class="col-md-5">
        <img src="images/paper-4.png" class="img-fluid rounded-start" alt="diabetes-induced myopathy">
      </div>
      <div class="col-md-7">
        <div class="card-body">
          <h4 class="card-title">
            Quercetin and Kaempferol Mitigate Endotoxin-Induced Skeletal Muscle Wasting by Inhibiting KLF15 Expression and Restoring the Antioxidant System
          </h4>
          <p class="card-text">In this study, we demonstrate that the natural flavonoids quercetin and kaempferol can effectively mitigate skeletal muscle atrophy induced by bacterial endotoxin (lipopolysaccharide, LPS) in muscle cells. Using C2C12 myoblasts and myotubes, the study reveals that both compounds, especially in combination, significantly reduce oxidative stress, suppress pro-inflammatory signaling (TLR4, NF-Œ∫B, IL-6), and restore mitochondrial membrane potential. Mechanistically, they inhibit the expression of the atrophy-associated transcription factor KLF15, activate antioxidant enzymes (Nrf2, SOD2), and reactivate protein synthesis pathways (mTOR, p70S6K), thereby promoting myogenesis and muscle integrity. These findings highlight the therapeutic potential of quercetin and kaempferol‚Äîcommonly found in tea leaves, onions, and leafy greens‚Äîin combating inflammation-induced muscle wasting, such as that seen in sepsis.</p>
          <p class="card-text"><small class="text-body-secondary">The FASEB journal</small></p>
          <a class="btn btn-light" href="https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202501184R" role="button">Read more</a>
        </div>
      </div>
    </div>
  </div>
</div>


<div class="container d-flex justify-content-center mb-3">
  <div class="card mb-3" style="max-width: 1080px;">
    <div class="row g-0">
      <div class="col-md-5">
        <img src="images/paper-2.png" class="img-fluid rounded-start" alt="Myostatin">
      </div>
      <div class="col-md-7">
        <div class="card-body">
          <h4 class="card-title">
            The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis
          </h4>
          <p class="card-text">The research paper discusses the crucial role of myostatin in skeletal muscle regeneration and its implications for conditions such as sarcopenia, muscular dystrophies, and cachexia. The paper highlights how skeletal muscles play a vital role in the musculoskeletal system and how their proper functioning is essential for stability and mobility. Improper functioning of skeletal muscles can lead to diseases like sarcopenia, muscular dystrophies, and cachexia. The paper focuses on the interplay of signaling pathways involved in skeletal muscle regeneration, hypertrophy, atrophy, and degeneration, with myostatin being a significant regulator. It discusses the impact of myostatin on muscle mass regulation, highlighting its involvement in conditions like cachexia and inflammatory processes in rheumatoid arthritis. Clinical trials of various myostatin inhibitors and activators are reviewed, showing varying degrees of efficacy and safety profiles. The potential of targeting myostatin for therapeutic interventions in muscle-wasting disorders and inflammatory bone diseases is emphasized, offering hope for improved treatment strategies in the future.</p>
          <p class="card-text"><small class="text-body-secondary">Osteoporosis and Sarcopenia</small></p>
          <a class="btn btn-light" href="https://www.sciencedirect.com/science/article/pii/S2405525523000092?via%3Dihub" role="button">Read more</a>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container d-flex justify-content-center mb-3">
  <div class="card mb-3" style="max-width: 1080px;">
    <div class="row g-0">
      <div class="col-md-5">
        <img src="images/paper-3.png" class="img-fluid rounded-start" alt="Obestatin">
      </div>
      <div class="col-md-7">
        <div class="card-body">
          <h4 class="card-title">
            Unlocking the Potential of Obestatin: A Novel Peptide Intervention for Skeletal Muscle Regeneration and Prevention of Atrophy
          </h4>
          <p class="card-text">The research paper explores the potential of obestatin, a peptide derived from the same gene as ghrelin, in preventing skeletal muscle wasting and inducing myogenesis. Obestatin functions through the GPR39 receptor, similar to ghrelin, and targets proteins like FoxO family members to combat skeletal muscle atrophy. It induces the transcription of Pax7, crucial for muscle stem cell mobilization. The paper discusses the anti-atrophic effects of obestatin compared to ghrelin, highlighting their synergistic and complementary activities. Mechanistic studies reveal the role of obestatin in inhibiting FoxO4 and the autophagy pathway, crucial for muscle wasting. Furthermore, obestatin influences intracellular signaling pathways involving CaMK II and ERK1/2 for muscle regeneration. The paper suggests a potential therapeutic role for obestatin in preventing skeletal muscle atrophy and sarcopenia, emphasizing the need for further research on obestatin's clinical applications in combination therapies.</p>
          <p class="card-text"><small class="text-body-secondary">Molecular Biotechnology</small></p>
          <a class="btn btn-light" href="https://link.springer.com/article/10.1007/s12033-023-01011-7" role="button">Read more</a>
        </div>
      </div>
    </div>
  </div>
</div>

<hr class="mx-auto full-line">
<!-- Footer -->
<div class="container">
  <p class="text-center ">
      Reach out to me at <a href="mailto:akamitra20@gmail.com" class="text-danger">akamitra20@gmail.com</a>
  </p>
  <p class="text-center">
      Made with ‚ô•Ô∏é and Bootstrap
  </p>
</div>




    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js" integrity="sha384-YvpcrYf0tY3lHB60NNkmXc5s9fDVZLESaAA55NDzOxhy9GkcIdslK1eN7N6jIeHz" crossorigin="anonymous"></script>   
</body>
</html>